News

The purpose of the studies was to compare the safety of VaxGen’s attenuated vaccine candidate, LC16m8, with that of the unattenuated Lister strain of the vaccine, from which

In March 2005, Coley and Pfizer entered into an exclusive global license agreement to develop, manufacture and commercialize Coley’s PF-3512676, a Toll-like receptor 9 (TLR9) agonist delivered by

The new company will market and develop Abraxane, which is approved in the US for metastatic breast cancer and is being developed for adjuvant breast, lung, ovarian, prostate,

The results are a disappointment to the Swiss company as it seeks to expand the indication and market for its lead product. In the idiopathic pulmonary fibrosis (IPF)

“Understanding how personality is based in the brain is important both for insights into personality disorders and for conditions in which personality may confer vulnerability, such as anxiety

According to the study data, some traditional non-steroidal anti-inflammatory drugs (NSAIDs) can slightly increase the risk of non-fatal heart attack when taken regularly for more than one year.

The protein is the first clear target for modulating where viruses insert into the human genome, which has implications for better design of gene-therapy delivery. Retroviral vectors are

Previously, it was not known if zinc would speed up HIV disease progression in children by increasing their viral load. Zinc supplementation is known to decrease the frequency

The vaccine platform developed by Children’s Hospital of Pittsburgh researchers, working in collaboration with researchers from the University of Pittsburgh and Louisiana State University, suggests that the immune